Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. - Wikidata - wikimedia - TriplyDB

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

http://www.wikidata.org/entity/Q30459060

about

Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults Treatment of dental complications in sickle cell disease Preoperative blood transfusions for sickle cell disease Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews Interventions for treating intrahepatic cholestasis in people with sickle cell disease Psychological therapies for sickle cell disease and pain Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease Novel insights in the management of sickle cell disease in childhood Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia Sickle cell disease: wheeze or asthma?The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challenges Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future Research Biomarkers and recent advances in the management and therapy of sickle cell disease Update of hematopoietic cell transplantation for sickle cell disease 2015 Clinical trials update in sickle cell anemia Pragmatic medicine in solid cancer: a translational alternative to precision medicine Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease The European Hematology Association Roadmap for European Hematology Research: a consensus document Bacteremia in Patients with Heterotaxy: A Review and Implications for Management.How I manage cerebral vasculopathy in children with sickle cell disease.Determining Adherence to Quality Indicators in Sickle Cell Anemia Using Multiple Data Sources.Effects of hydroxyurea treatment for patients with hemoglobin SC disease.A Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease.Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.Efficacy and Safety of Manual Partial Red Cell Exchange in the Management of Severe Complications of Sickle Cell Disease in a Developing Country.Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks.Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.Anti-Toxoplasma gondii antibodies in patients with beta-hemoglobinopathies: the first report in the Americas Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease.Increased risk of severe vaso-occlusive episodes after initial acute chest syndrome in children with sickle cell anemia less than 4 years old: Sleep and asthma cohort.How I treat and manage strokes in sickle cell disease.Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision.Updated Mechanisms of Sickle Cell Disease-Associated Chronic pain Sickle Cell Trait from a Metabolic, Renal, and Vascular Perspective: Linking History, Knowledge, and Health.Pulmonary function indices in children with sickle cell anemia in Enugu, south-east Nigeria Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia.Mortal quintet of sickle cell diseases.

P2860

Q24185822-C2189454-3DE1-4661-AD63-89918D3CB70E Q24185872-BD48E03A-7366-42DD-8A1D-65309E4B06EF Q24185919-8F6085BC-AA63-4646-9C04-048EC3E9F3BB Q24186232-805AD3DD-382A-42EC-BCAF-C70C83AE874C Q24187279-3E839663-8DF3-4DF3-875B-FE4069685B47 Q24188007-27B4127F-87E4-4CAD-8C36-19BB8131666C Q26471968-F993D592-6B2A-4B28-BC3A-BBB491D6039A Q26767015-90839682-283A-4ED8-BAD2-9A64B606BF55 Q26779359-E40A922A-93CD-4565-A66C-89D3A25782A6 Q28066466-EDD4EB43-DF7D-48B3-A006-CD325A37063A Q28072698-A6809AD0-4AA2-4E68-9494-7F7806FC5B7B Q28077484-D7232E62-FD91-45BD-ABAC-52A7270AAA0F Q28079225-9D08C650-2066-4E78-8C2D-92F98B856498 Q28082462-FE5BA61A-5FC4-488A-87BB-A31699A5051A Q28083007-19C49209-B9D2-4ADC-9E8E-75E39EEDF158 Q28086979-5CD7781D-514D-4F62-B1DE-E7677A2070C8 Q28391863-2FDDE43C-F8DB-4973-934D-F5284EDD874D Q28828635-BEF84EF8-54EB-465E-A9AB-076A23D7757B Q28830861-2B00EE36-0CE3-4F90-99E7-66C78C5AE9E4 Q30248957-C525CBF9-A912-4C4E-BE5F-CC4B601A1A3C Q30945117-B555A7B6-7BCC-45EF-846A-062E3623BAE6 Q31109048-A3B0D90F-7EA8-4E38-A92B-B38A7F4756FF Q33427950-3F52814A-039B-46BF-82B8-3A0A49858C66 Q33440070-765E0514-0831-4E15-834D-E4FEFE6CB7B2 Q33552132-9ED25322-29F3-465D-B322-A4B1849D5AE3 Q33679897-50398A58-2695-4EE2-AB0A-76C627E470A1 Q33726299-B8B7FF17-1E18-4CBD-B6DB-C145026BFA71 Q33746698-6AE1D66E-20A8-491B-99D2-80A53C9C3506 Q33755816-BA023BEA-A089-4504-847E-E4E716E5BD75 Q33802332-1085D178-C5CB-4E97-83FE-F0CB639C05CC Q33876417-8DC4F8BD-F6D1-4273-997E-513EBD597D38 Q34639791-1B42FE7E-6E37-49D3-9162-577549AD60B1 Q35537070-8088D903-DB7F-463A-A344-10AF48296C81 Q35743944-33F21AC4-5856-4F64-8742-142553DC61B4 Q35754065-AB1D5265-75FC-441B-841C-C7928BF366F2 Q35972703-CF18A3EB-E0E2-43E6-B0BE-CE65E79AFAB0 Q35994946-D3486DAF-DDE5-43DA-9D11-EC663EA058A0 Q35996218-34CC3282-A9D3-40AB-AA0F-DB0DF7153CF1 Q35999807-26783BA6-BB00-4BB3-AA35-23347FA729FF Q36046731-C23BA2DD-5660-4277-9124-1B4BAF357E2B

P2860

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

http://www.wikidata.org/entity/Q30459060

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Management of sickle cell dise ...... eport by expert panel members.

@ast

Management of sickle cell dise ...... eport by expert panel members.

@en

type

label

Management of sickle cell dise ...... eport by expert panel members.

@ast

Management of sickle cell dise ...... eport by expert panel members.

@en

prefLabel

Management of sickle cell dise ...... eport by expert panel members.

@ast

Management of sickle cell dise ...... eport by expert panel members.

@en

P1433

Q30459060-0119A9A1-B9AC-4146-B326-7DE9D072C73E

P1476

Q30459060-ADAB02C7-CCA4-417A-A421-C4508B3BD736

P2093

Q30459060-04A850CB-A572-422E-99DB-FB24FFBE0A11

Q30459060-167BD461-C19C-483A-8E5F-57E3C04A9CAA

Q30459060-3200106E-1AE2-450C-BCCB-FF8BC70A3185

Q30459060-34DB6B0B-D7A8-42DB-B5A9-D62A24AAC50D

Q30459060-36395659-3CD7-4B00-9669-29D90A63B5FB

Q30459060-5465F82F-4789-4DB2-9F36-C37840D8B2DE

Q30459060-60341CA9-835B-4716-9D2E-B3B57C2A88F1

Q30459060-9C7E1B8F-433A-4E0C-839F-D624DF71EDBD

Q30459060-9F4CF380-1E21-488E-8A5D-D9DDE683A775

Q30459060-A0809D82-F496-4670-BDD4-C2D3D2FEDE34

P304

Q30459060-68ACEBFF-0155-4361-A5A2-543F725EF87F

P31

Q30459060-4b03b9cb-8218-4a12-938f-c85456d9493b

Q30459060-A9462CA4-FDA3-4D8C-B465-C24E43350AC3

P356

Q30459060-D6BCD515-9E72-480A-BB9A-BCEF923301F0

P407

Q30459060-025ECFDB-3D99-4F4C-9F05-3EA3C0BB9CA1

P433

Q30459060-8463483D-97BB-462A-9067-BC58198002A0

P478

Q30459060-DF770840-0FEE-4371-9B90-DFE65EA20948

P577

Q30459060-A66FA9B5-FF8A-4D56-871F-C9EAF7D42DF4

P5875

Q30459060-DF3D4D63-C722-4408-AAC5-8060B07456D8

P698

Q30459060-3597A245-5B57-4A6E-8F76-B080D4F9369F

P921

Q30459060-732B5CD0-BCFC-49B9-A1E1-2A8256171139

P356

JAMA.2014.10517

P1433

Journal of the American Medical Association

P1476

Management of sickle cell dise ...... eport by expert panel members.

@en

P2093

Andra H James

http://www.w3.org/2001/XMLSchema#string

Ann Horton

http://www.w3.org/2001/XMLSchema#string

Araba N Afenyi-Annan

http://www.w3.org/2001/XMLSchema#string

Barbara P Yawn

http://www.w3.org/2001/XMLSchema#string

Eduardo Ortiz

http://www.w3.org/2001/XMLSchema#string

George R Buchanan

http://www.w3.org/2001/XMLSchema#string

Jonathan C Goldsmith

http://www.w3.org/2001/XMLSchema#string

Joylene John-Sowah

http://www.w3.org/2001/XMLSchema#string

Kathryn L Hassell

http://www.w3.org/2001/XMLSchema#string

Lanetta Jordan

http://www.w3.org/2001/XMLSchema#string

P304

1033-1048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2014.10517

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

312

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265473838

http://www.w3.org/2001/XMLSchema#string

P698

25203083

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease